Museum Dr. Guislain and Janssen Research Development, LLC Issue Global Call for Nominations for 2015 Dr. Guislain Breaking the Chains of Stigma Award

Food and Healthcare Press Releases Tuesday March 10, 2015 10:30
GHENT, Belgium--10 Mar--PRNewswire/InfoQuest

The Museum Dr. Guislain in Ghent, Belgium, and Janssen Research & Development, LLC ("Janssen") today announced they are seeking nominations for the fourth annual Dr. Guislain "Breaking the Chains of Stigma" Award. The award honours an individual, project or organisation that has made an exceptional contribution to reduce stigma associated with mental illness.

(Photo: )
(Photo: )

Nominations from people and organisations across the globe can be submitted at, and will be accepted until 31 March 2015. A $50,000 prize will be awarded to the individual or group receiving the award, which must be used toward further work to reduce societal stigma about mental illness.

The winning individual, project or organisation will be determined by an independent selection committee of international advocates and renowned authorities in the field of mental health, and honoured at a ceremony on 8 October 2015 in Ghent, Belgium.

Museum Dr. Guislain and Janssen jointly sponsor the award, with funding provided by Janssen. Both organisations have a rich heritage and long-standing involvement in the field of mental illness research, treatment and education.

About the Dr. Guislain "Breaking the Chains of Stigma" Award

Individuals, organisations or projects from around the world that have made an exceptional contribution in dealing with, or promoting the awareness of, mental health care are eligible to receive the Dr. Guislain "Breaking the Chains of Stigma" Award. The Award is given to an individual(s), organisation or project that:

  • has made an exceptional contribution to mental healthcare in the broadest sense on a cultural and/or social level;
  • has provided a genuine contribution to decreasing stigma around mental health conditions;
  • has promoted attention for mental health care;
  • and has done all this with passion, creativity and innovation.
Source: Museum Dr. Guislain

Latest Press Release

Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity

Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body weight after 52 weeks in a phase 2 trial, significantly more than those treated with placebo who lost 2.3% of their...

FDI Global Survey Shows Children are not Getting Dental Check-ups Early Enough

On the occasion of World Oral Health Day, FDI World Dental Federation asked parents around the world how they cared for their children's oral health growing up and the responses suggest room for improvement. Maintaining a healthy mouth is crucial to...

Texas Cardiac Arrhythmia Institute at St. David#s Medical Center draws cardiac experts from across the globe for EPLive 2018

On March 1 and 2, 2018, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center hosted its fourth international symposium on complex arrhythmias, EPLive 2018. Nearly 200 leaders in the field of electrophysiology (EP) from Europe, Asia...

Johnson Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.

Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for approximately $2.1 billion, subject to customary adjustments. LifeScan,...

Biotherm Hosts the First Biotherm Healing Summit

Biotherm hosted the first "Biotherm Healing Summit" on March 7. A symposium on the theme of skin & healing, focusing on major research that has evidenced the link between micro-organisms and skin health. Unveiling Life PlanktonTM, the healing...

Related Topics